Entries by aaron

Medical Negligence? Patient alleges toes amputated without consent at Alappuzha MCH

Alappuzha: In a case of alleged medical negligence, a 58-year-old woman from Kuthiyathodu has accused the doctors in the surgery department of Alappuzha Medical College Hospital of amputating two toes on her right foot without her or her family’s consent.  While the woman and her family claimed that they were not informed about the amputation […]

51 Lakh people in India are at risk of contracting Chikungunya in the Long Term: Study

India is projected to face the most significant long-term impact of chikungunya, with an estimated 51 lakh people at risk annually, according to a global modelling study published in BMJ Global Health. Brazil and Indonesia follow as the second and third most affected countries, with India and Brazil together accounting for 48% of the global […]

15 Indian psychiatrists, doctors, scientists listed in Stanford 2025 List of World’s Top 2% Scientists

New Delhi: A total of 15 psychiatrists from India’s leading health and medical institutions have been recognised in the Stanford list of the world’s top 2% scientists. The prestigious database, curated by Professor John P.A. Ioannidis of Stanford University in collaboration with the Elsevier Data Repository, acknowledges their pioneering research, clinical excellence, and sustained impact in […]

Health Bulletin 04/October/2025

Here are the top health stories of the day: Attacks on doctors threaten Lives and patient safety in Hospitals: Delhi HC Warns While considering a criminal case against a patient’s attendant who had allegedly assaulted a doctor, the Delhi High Court bench took note of the compromise entered into between the parties and held that […]

CDSCO Flags MSD Pharma’s Cancer Drug Trial Over Indian Representation, Control Arm

New Delhi: The Subject Expert Committee (SEC) on Oncology under the Central Drugs Standard Control Organization (CDSCO) has raised critical concerns over the Phase III clinical trial proposal of Sacituzumab Tirumotecan submitted by MSD Pharmaceuticals Pvt. Ltd., directing the company to provide detailed justifications regarding its study design and patient representation in India. MSD Pharmaceuticals […]

Pharmacist Suspended, New Dispensing Guidelines Issued in Rajasthan Amid Cough Syrup Row

Jaipur: The cough syrup controversy in Rajasthan has now led to suspensions and sweeping new guidelines, as the health department cracked down on lapses following the deaths of children allegedly linked to dextromethorphan hydrobromide syrup. The state government suspended a pharmacist and a doctor of Hathideh PHC in Ajitgarh block, Sikar, for allegedly prescribing the […]

Orthopaedic Surgeon accused of exploiting woman over marriage promise

Thane: An orthopaedic surgeon from Ambernath has been accused of sexual exploitation by a woman. The woman, whose husband was earlier treated by the doctor, alleged that he took advantage of her following her husband’s death.  Alleging the doctor sexually assaulted her under the pretext of marriage, the widow filed a complaint against the doctor, […]

DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&D

New Delhi: The Department of Pharmaceuticals (DoP) has notified major amendments to the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) through a recent Gazette notification, with a massive financial outlay of Rs 5000 crore from FY 2023-24 to FY 2029-30. The scheme aims to transform India’s pharma and MedTech sector […]

GLP-1RAs Show Promise for Kidney Protection in Type 2 Diabetes, Reveals Research

Italy: A new review published in Minerva Medica has revealed that GLP-1 receptor agonists may help preserve kidney function in people with type 2 diabetes. Researchers led by Alessandro Perencin from the Department of Medicine (DIMED), Geriatrics Division, University of Padua, Italy, conducted a systematic review to examine whether this class of diabetes medications could […]

GLP-1 Receptor Agonists Show Gastrointestinal Safety with Some Risks: Study

USA: Researchers have found in a retrospective study that GLP-1 receptor agonists (RAs) are generally safe for the gastrointestinal (GI) and hepatobiliary systems in patients with type 2 diabetes (T2D).     The study published in the American Journal of Gastroenterology revealed that the therapy was linked to lower risks of several GI cancers and complications compared with […]